Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure
Clinical trial NCT01461577 · COMPLETED
Trial details
- NCT number
- NCT01461577
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-12-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.